These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 26073366

  • 21. Intensive menstrual bleeding successfully treated with recombinant factor VIIa in Glanzmann thrombasthenia.
    Balci YI, Karabulut A, Kabukcu S, Sari I, Keskin A.
    Clin Appl Thromb Hemost; 2011 Aug; 17(4):320-2. PubMed ID: 20460355
    [Abstract] [Full Text] [Related]

  • 22. Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders.
    Shima M.
    Ann Hematol; 2024 Aug; 103(8):2647-2658. PubMed ID: 37391649
    [Abstract] [Full Text] [Related]

  • 23. Recombinant activated factor VII in clinical practice: a 2014 update.
    Franchini M, Crestani S, Frattini F, Sissa C, Bonfanti C.
    J Thromb Thrombolysis; 2015 Feb; 39(2):235-40. PubMed ID: 25015059
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Safety update on the use of recombinant activated factor VII in approved indications.
    Neufeld EJ, Négrier C, Arkhammar P, Benchikh el Fegoun S, Simonsen MD, Rosholm A, Seremetis S.
    Blood Rev; 2015 Jun; 29 Suppl 1():S34-41. PubMed ID: 26073367
    [Abstract] [Full Text] [Related]

  • 26. The use of recombinant factor VIla in a primigravida with Glanzmann's thrombasthenia during delivery.
    Kale A, Bayhan G, Yalinkaya A, Yayla M.
    J Perinat Med; 2004 Jun; 32(5):456-8. PubMed ID: 15493726
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Surgical procedures in patients with Glanzmann's thrombasthenia: case series and literature review.
    Ganapule A, Jain P, Abubacker FN, Korula A, Abraham A, Mammen J, George B, Mathews V, Srivastava A, Viswabandya A.
    Blood Coagul Fibrinolysis; 2017 Mar; 28(2):171-175. PubMed ID: 27273143
    [Abstract] [Full Text] [Related]

  • 29. Management of Abdominal Aortic Aneurysm Surgery in Glanzmann's Thrombasthenia Patients with Anti-GPIIb-IIIa Antibodies: A Case Report.
    Leuci A, Millon A, Chopin A, Rezigue H, Alotaibi S, Dargaud Y.
    J Clin Med; 2024 Sep 30; 13(19):. PubMed ID: 39407899
    [Abstract] [Full Text] [Related]

  • 30. Perioperative management of a pediatric patient with Glanzmann's thrombasthenia during adenoidectomy.
    Duman EN, Saylan S, Cekic B.
    Rev Bras Anestesiol; 2012 Jul 30; 62(4):548-53. PubMed ID: 22793971
    [Abstract] [Full Text] [Related]

  • 31. A case of Glanzmann's thrombasthenia successfully treated with recombinant factor viia during a surgical procedure: observations on the monitoring and the mechanism of action of this drug.
    Dargaud Y, Bordet JC, Trzeciak MC, Vinciguerra C, Negrier C.
    Haematologica; 2006 Jun 30; 91(6 Suppl):ECR20. PubMed ID: 16785139
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency.
    Gorkom BL, Holme PA, Joch C, Rogosch T, Feussner A, McKeand W, Roberts J, van Heerde W.
    Hematology; 2020 Dec 30; 25(1):17-25. PubMed ID: 31852380
    [Abstract] [Full Text] [Related]

  • 33. Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures.
    d'Oiron R, Ménart C, Trzeciak MC, Nurden P, Fressinaud E, Dreyfus M, Laurian Y, Négrier C.
    Thromb Haemost; 2000 May 30; 83(5):644-7. PubMed ID: 10823254
    [Abstract] [Full Text] [Related]

  • 34. Low Concentrations of Recombinant Factor VIIa May Improve the Impaired Thrombin Generation of Glanzmann Thrombasthenia Patients.
    Levy-Mendelovich S, Levy T, Budnik I, Barg AA, Rosenberg N, Seligsohn U, Kenet G, Livnat T.
    Thromb Haemost; 2019 Jan 30; 119(1):117-127. PubMed ID: 30597506
    [Abstract] [Full Text] [Related]

  • 35. [Use of recombinant factor VII in Glanzmann thrombasthenia: a case report].
    Chabchoub Ben Abdallah R, Trabelsi L, Ben Ameur S, Kammoun F, Boukédi A, Ben Salah M, Ben Hlima N, Mahfoudh A.
    Arch Pediatr; 2010 Jul 30; 17(7):1062-4. PubMed ID: 20570498
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.
    Di Minno G, Zotz RB, d'Oiron R, Bindslev N, Di Minno MN, Poon MC, Glanzmann Thrombasthenia Registry Investigators.
    Haematologica; 2015 Aug 30; 100(8):1031-7. PubMed ID: 26001793
    [Abstract] [Full Text] [Related]

  • 39. Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
    Parameswaran R, Shapiro AD, Gill JC, Kessler CM, HTRS Registry Investigators.
    Haemophilia; 2005 Mar 30; 11(2):100-6. PubMed ID: 15810910
    [Abstract] [Full Text] [Related]

  • 40. NovoSeven as a universal haemostatic agent.
    Hedner U.
    Blood Coagul Fibrinolysis; 2000 Apr 30; 11 Suppl 1():S107-11. PubMed ID: 10850574
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.